Gladem
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
415 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | — | F33.9 | 8 | 40 | 47 | 61 | 74 | 221 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | 11 | 40 | 50 | 55 | 58 | 204 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 7 | 22 | 24 | 30 | 33 | 113 |
| Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 4 | 5 | 8 | 13 | 7 | 35 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | 7 | 5 | 9 | 12 | 32 |
| Traumatic stress disorders | D040921 | — | — | 3 | 4 | 7 | 10 | 4 | 26 |
| Obsessive-compulsive disorder | D009771 | EFO_0004242 | F42 | — | 2 | 3 | 8 | 8 | 20 |
| Compulsive personality disorder | D003193 | — | F60.5 | — | 2 | 3 | 8 | 6 | 18 |
| Healthy volunteers/patients | — | — | — | 14 | — | — | 2 | 2 | 18 |
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 1 | 2 | 5 | 3 | 3 | 13 |
Show 53 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | 2 | — | 3 | 5 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | 1 | — | 3 | 5 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | 1 | 1 | — | 3 | 4 |
| Separation anxiety | D001010 | EFO_1001916 | — | — | 1 | 1 | — | 2 | 4 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 3 | 1 | — | — | 4 |
| Cognitive dysfunction | D060825 | — | G31.84 | — | — | 1 | — | 3 | 4 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 1 | 2 | — | — | 4 |
| Sleep initiation and maintenance disorders | D007319 | — | F51.01 | — | 1 | 2 | — | 1 | 3 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | 1 | — | 1 | 3 |
| Brain injuries | D001930 | — | S06.9 | — | 1 | 1 | — | 2 | 3 |
Show 30 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Autism spectrum disorder | D000067877 | — | F84.0 | — | 3 | — | — | 1 | 4 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | 2 | — | — | 2 | 4 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | 2 | 1 | — | — | 1 | 3 |
| Pervasive child development disorders | D002659 | EFO_0003756 | F84 | — | 2 | — | — | — | 2 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 1 | — | — | 1 | 2 |
| Hepatitis c | D006526 | — | B19.2 | 1 | 1 | — | — | — | 2 |
| Fragile x syndrome | D005600 | — | Q99.2 | — | 2 | — | — | — | 2 |
| Cocaine-related disorders | D019970 | — | F14 | — | 2 | — | — | — | 2 |
| Pruritus | D011537 | — | L29 | — | 2 | — | — | — | 2 |
| Glioblastoma | D005909 | EFO_0000515 | — | 1 | 1 | — | — | — | 1 |
Show 22 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Overweight | D050177 | — | E66.3 | 1 | — | — | — | 1 | 2 |
| Huntington disease | D006816 | Orphanet_399 | G10 | 1 | — | — | — | — | 1 |
| Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
| Myeloid leukemia | D007951 | — | C92 | 1 | — | — | — | — | 1 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
| Preleukemia | D011289 | — | — | 1 | — | — | — | — | 1 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | 1 | — | — | — | — | 1 |
| Vertigo | D014717 | — | H81.39 | 1 | — | — | — | — | 1 |
| Dizziness | D004244 | — | R42 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Taste disorders | D013651 | — | — | — | — | — | — | 3 | 3 |
| Psychological distress | D000079225 | — | — | — | — | — | — | 3 | 3 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | — | 2 | 2 |
| Suicidal ideation | D059020 | EFO_0004320 | R45.851 | — | — | — | — | 2 | 2 |
| Hypoglycemia | D007003 | — | E16.2 | — | — | — | — | 2 | 2 |
| Affective symptoms | D000342 | — | — | — | — | — | — | 2 | 2 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
| Hot flashes | D019584 | — | — | — | — | — | — | 2 | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | — | 1 | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Show 65 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use